ALLO NASDAQ
Allogene Therapeutics, Inc.
1W: -8.4%
1M: -18.0%
3M: -4.4%
YTD: +45.2%
1Y: +69.0%
3Y: -68.0%
5Y: -92.9%
$2.00
+0.04 (+2.04%)
Weekly Expected Move ±8.1%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-174M
Net Income
+31.1% YoY
$-110M
Free Cash Flow
+44.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-48.6%
ROA-36.0%
ROIC-128.0%
Valuation
P/E-2.8
P/B1.7
EV/EBITDA-2.4
Leverage
Debt/Equity0.26
Current Ratio7.93
Interest Cov.-147.1x
Quality Scores
Piotroski F2/9
Altman Z-4.70
Beneish M0.00